We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.37B
AUM Growth
-$79.1M
Cap. Flow
-$328M
Cap. Flow %
-23.94%
Top 10 Hldgs %
16.21%
Holding
364
New
83
Increased
69
Reduced
93
Closed
66

Top Buys

Rank Stock Value
1
WYNN icon
Wynn Resorts
WYNN
+$22.1M
2
LVS icon
Las Vegas Sands
LVS
+$21.2M
3
TAP icon
Molson Coors Class B
TAP
+$7.08M
4
OA
Orbital ATK, Inc.
OA
+$6.56M
5
GGG icon
Graco
GGG
+$6.07M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$10.5M
2
HHH icon
Howard Hughes
HHH
+$9.77M
3
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$9.72M
4
JACK icon
Jack in the Box
JACK
+$9.49M
5
EXPE icon
Expedia Group
EXPE
+$8.47M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18%
2 Technology 12.96%
3 Industrials 9.99%
4 Financials 7.69%
5 Healthcare 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMX
226
Himax Technologies
HIMX
$2.55B
$1.22M 0.09%
+108,445
New +$952K
XOM icon
227
ExxonMobil
XOM
$634B
$1.21M 0.09%
+14,419
New +$1.15M
JPM icon
228
JPMorgan Chase
JPM
$950B
$1.2M 0.09%
20,172
-10,422
-34% -$609K
SYNT
229
DELISTED
Syntel Inc
SYNT
$1.19M 0.09%
23,847
– –
GILD icon
230
Gilead Sciences
GILD
$165B
$1.17M 0.09%
12,733
-6,923
-35% -$624K
INFN
231
DELISTED
Infinera Corporation Common Stock
INFN
$1.16M 0.09%
72,472
-37,281
-34% -$572K
PTLA
232
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.1M 0.08%
53,746
-35,845
-40% -$1.14M
RDUS
233
DELISTED
Radius Health, Inc.
RDUS
$1.03M 0.08%
32,879
-3,066
-9% -$106K
MCK icon
234
McKesson
MCK
$101B
$952K 0.07%
+6,055
New +$978K
LIND icon
235
Lindblad Expeditions
LIND
$2.22B
$940K 0.07%
+94,568
New +$954K
TSRO
236
DELISTED
TESARO, Inc.
TSRO
$914K 0.07%
+20,758
New +$833K
SEAC
237
DELISTED
Seachange International Inc
SEAC
$853K 0.06%
7,728
-14,910
-66% -$1.73M
COLL icon
238
Collegium Pharmaceutical
COLL
$956M
$849K 0.06%
+46,773
New +$850K
SCOR icon
239
Comscore
SCOR
$109M
$792K 0.06%
1,318
-2,068
-61% -$1.5M
FTRPR
240
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
$712K 0.05%
+6,820
New +$637K
INXN
241
DELISTED
Interxion Holding N.V.
INXN
$689K 0.05%
+19,927
New +$620K
HMTV
242
DELISTED
Hemisphere Media Group, Inc.
HMTV
$687K 0.05%
52,333
+16,670
+47% +$230K
TAST
243
DELISTED
Carrols Restaurant Group, Inc.
TAST
$666K 0.05%
+46,132
New +$602K
VG
244
DELISTED
Vonage Holdings Corporation
VG
$652K 0.05%
142,624
-410,633
-74% -$2.03M
BLUE
245
DELISTED
bluebird bio
BLUE
$513K 0.04%
932
-483
-34% -$297K
CLLS
246
Cellectis
CLLS
$285M
$513K 0.04%
18,662
-5,090
-21% -$123K
SQBG
247
DELISTED
Sequential Brands Group, Inc.
SQBG
$310K 0.02%
1,214
-5,673
-82% -$1.47M
UNP icon
248
Union Pacific
UNP
$174B
$290K 0.02%
+3,645
New +$282K
AVGR
249
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
-1
Closed -$1.7M
ACAD icon
250
Acadia Pharmaceuticals
ACAD
$5.03B
– –
-55,254
Closed -$1.97M
8 9
10
11 12

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2016 Portfolio in Review

As of Q1 2016, Nicholas Investment Partners held 364 positions worth $1.37B, down 5.5% from $1.45B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Nicholas Investment Partners withdrew a net $328M in Q1 2016, closing 66 positions and reducing 93 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Wynn Resorts worth $28M.

  • Nicholas Investment Partners's largest Q1 2016 buy was Wynn Resorts: 300,000 shares worth $28M.
  • Nicholas Investment Partners added most to Las Vegas Sands in Q1 2016, an estimated $21.2M increase.
  • Nicholas Investment Partners's biggest Q1 2016 reduction was Vail Resorts, cutting an estimated $6.84M.
  • Nicholas Investment Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016, selling an estimated $10.5M.
  • Nicholas Investment Partners's ten largest holdings make up 16% of its $1.37B portfolio in Q1 2016.
  • Nicholas Investment Partners opened 83 new positions and closed 66 in Q1 2016.
  • Nicholas Investment Partners's portfolio value fell 5.5% quarter-over-quarter to $1.37B.

Based on Nicholas Investment Partners's 13F filing for Q1 2016, filed 13 May 2016.